AAAAAA
Results:
1-16
|
Results: 16
Authors:
Williamson, M
Naaby-Hansen, S
Masters, JRW
Citation: M. Williamson et al., 21st Century molecular biology in urology, BJU INT, 88(5), 2001, pp. 451-457
Authors:
Wang, XG
Masters, JRW
Wong, YC
Lo, AKF
Tsao, SW
Citation: Xg. Wang et al., Mechanism of differential sensitivity to cisplatin in nasopharyngeal carcinoma cells, ANTICANC R, 21(1A), 2001, pp. 403-408
Authors:
Rossi, MR
Masters, JRW
Park, S
Todd, JH
Garrett, SH
Sens, MA
Somji, S
Nath, J
Sens, DA
Citation: Mr. Rossi et al., The immortalized UROtsa cell line as a potential cell culture model of human urothelium, ENVIR H PER, 109(8), 2001, pp. 801-808
Authors:
Hudson, DL
Guy, AT
Fry, P
O'Hare, MJ
Watt, FM
Masters, JRW
Citation: Dl. Hudson et al., Epithelial cell differentiation pathways in the human prostate: Identification of intermediate phenotypes by keratin expression, J HIST CYTO, 49(2), 2001, pp. 271-278
Authors:
Masters, JRW
Citation: Jrw. Masters, Human cancer cell lines: fact and fantasy, NAT REV MOL, 1(3), 2000, pp. 233-236
Authors:
Fry, PM
Hudson, DL
O'Hare, MJ
Masters, JRW
Citation: Pm. Fry et al., Comparison of marker protein expression in benign prostatic hyperplasia invivo and in vitro, BJU INT, 85(4), 2000, pp. 504-513
Authors:
Masters, JRW
Lakhani, SR
Citation: Jrw. Masters et Sr. Lakhani, How diagnosis with microarrays can help cancer patients, NATURE, 404(6781), 2000, pp. 921-921
Authors:
Hudson, DL
O'Hare, M
Watt, FM
Masters, JRW
Citation: Dl. Hudson et al., Proliferative heterogeneity in the human prostate: Evidence for epithelialstem cells, LAB INV, 80(8), 2000, pp. 1243-1250
Authors:
Masters, JRW
Twentyman, P
Daley, R
Davis, J
Doyle, A
Dyer, S
Freshney, I
Galpine, A
Harrison, M
Hurst, H
Kelland, L
Stacey, G
Stratford, I
Ward, TH
Citation: Jrw. Masters et al., UKCCCR guidelines for the use of cell lines in cancer research, BR J CANC, 82(9), 2000, pp. 1495-1509
Authors:
Bai, XZ
Masters, JRW
O'Donoghue, N
Kirby, R
Pan, LX
Young, M
Stafford, M
Parkinson, MC
Citation: Xz. Bai et al., Prognostic markers in clinically localised prostate cancer, INT J ONCOL, 14(4), 1999, pp. 785-791
Authors:
Koberle, B
Masters, JRW
Hartley, JA
Wood, RD
Citation: B. Koberle et al., Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours, CURR BIOL, 9(5), 1999, pp. 273-276
Authors:
Masters, JRW
Popert, RJM
Thompson, PM
Gibson, D
Coptcoat, MJ
Parmar, MKB
Citation: Jrw. Masters et al., Intravesical chemotherapy with epirubicin: A dose response study, J UROL, 161(5), 1999, pp. 1490-1493
Authors:
O'Neill, CF
Koberle, B
Masters, JRW
Kelland, LR
Citation: Cf. O'Neill et al., Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin, BR J CANC, 81(8), 1999, pp. 1294-1303
Authors:
Knuechel, R
Masters, JRW
Citation: R. Knuechel et Jrw. Masters, Bladder cancer, HUM CEL CUL, 1, 1999, pp. 213-230
Authors:
Wang, XH
Fox, M
Povey, S
Masters, JRW
Citation: Xh. Wang et al., Mouse-human somatic cell hybrids: Loss of mouse and human chromosomes, SOM CELL M, 24(3), 1998, pp. 165-171
Authors:
Sabbagh, W
Masters, JRW
Duffy, PG
Herbage, D
Brown, RA
Citation: W. Sabbagh et al., In vitro assessment of a collagen sponge for engineering urothelial grafts, BR J UROL, 82(6), 1998, pp. 888-894
Risultati:
1-16
|